DE602004003252D1 - Verwendung von 2h-ä1,3ü-oxazinoä3,2-aüindol-derivaten zur behandlung von neuropathischem schmerz - Google Patents

Verwendung von 2h-ä1,3ü-oxazinoä3,2-aüindol-derivaten zur behandlung von neuropathischem schmerz

Info

Publication number
DE602004003252D1
DE602004003252D1 DE602004003252T DE602004003252T DE602004003252D1 DE 602004003252 D1 DE602004003252 D1 DE 602004003252D1 DE 602004003252 T DE602004003252 T DE 602004003252T DE 602004003252 T DE602004003252 T DE 602004003252T DE 602004003252 D1 DE602004003252 D1 DE 602004003252D1
Authority
DE
Germany
Prior art keywords
oxazinoä3
ateindol
derivatives
treatment
neuropathic pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004003252T
Other languages
English (en)
Other versions
DE602004003252T2 (de
Inventor
Angelo Guglielmotti
Lorenzo Polenzani
Alessandra Alisi
Nicola Cazzolla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angelini Acraf SpA
Original Assignee
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA filed Critical Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Publication of DE602004003252D1 publication Critical patent/DE602004003252D1/de
Application granted granted Critical
Publication of DE602004003252T2 publication Critical patent/DE602004003252T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DE602004003252T 2003-07-18 2004-07-08 Verwendung von 2H-[1,3]-Oxazino[3,2]indol-Derivaten zur Behandlung von neuropathischem Schmerz Active DE602004003252T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT001467A ITMI20031467A1 (it) 2003-07-18 2003-07-18 Farmaco attivo nel dolore neuropatico
ITMI20031467 2003-07-18
PCT/EP2004/007633 WO2005014001A1 (en) 2003-07-18 2004-07-08 Use of 2h- [1, 3] - oxazino [3, 2-a] indole derivatives for the treatment of neuropathic pain

Publications (2)

Publication Number Publication Date
DE602004003252D1 true DE602004003252D1 (de) 2006-12-28
DE602004003252T2 DE602004003252T2 (de) 2007-05-03

Family

ID=34131193

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004003252T Active DE602004003252T2 (de) 2003-07-18 2004-07-08 Verwendung von 2H-[1,3]-Oxazino[3,2]indol-Derivaten zur Behandlung von neuropathischem Schmerz

Country Status (21)

Country Link
US (1) US20060211691A1 (de)
EP (1) EP1646391B1 (de)
JP (1) JP2006528142A (de)
KR (1) KR20060033784A (de)
CN (1) CN100409850C (de)
AR (1) AR045993A1 (de)
AT (1) ATE345137T1 (de)
AU (1) AU2004262876B2 (de)
CA (1) CA2526852C (de)
DE (1) DE602004003252T2 (de)
DK (1) DK1646391T3 (de)
EA (1) EA008927B1 (de)
ES (1) ES2276317T3 (de)
GE (1) GEP20084307B (de)
HK (1) HK1087027A1 (de)
IL (1) IL172156A0 (de)
IT (1) ITMI20031467A1 (de)
PL (1) PL1646391T3 (de)
PT (1) PT1646391E (de)
UA (1) UA81050C2 (de)
WO (1) WO2005014001A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8247458B2 (en) * 2006-12-26 2012-08-21 Taiho Pharmaceutical Co., Ltd. Therapeutic agent for diabetic neuropathy
DE102007058504A1 (de) 2007-12-05 2009-07-09 Acino Ag Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189041A (en) * 1990-11-16 1993-02-23 Syntex (U.S.A.) Inc. Tricyclic 5-ht3 receptor antagonists
GB9120628D0 (en) * 1991-09-27 1991-11-06 Fujisawa Pharmaceutical Co Pyrrolobenzoxazine derivatives and process for preparation thereof
CA2131797C (en) * 1992-03-12 2010-05-18 Laramie Mary Gaster Condensed indole derivatives as 5ht4-receptor antagonists
IL117438A (en) * 1995-03-16 2001-12-23 Lilly Co Eli Indazolecarboxamides, their preparation and pharmaceutical compositions containing them
CA2378243C (en) * 1999-08-04 2012-05-15 Icagen, Inc. Methods for treating or preventing pain and anxiety
US20040038874A1 (en) * 2002-08-22 2004-02-26 Osemwota Omoigui Method of treatment of persistent pain

Also Published As

Publication number Publication date
EA008927B1 (ru) 2007-08-31
EP1646391A1 (de) 2006-04-19
PL1646391T3 (pl) 2007-04-30
ES2276317T3 (es) 2007-06-16
WO2005014001A9 (en) 2005-05-26
AU2004262876B2 (en) 2010-05-20
CN100409850C (zh) 2008-08-13
AR045993A1 (es) 2005-11-23
JP2006528142A (ja) 2006-12-14
ATE345137T1 (de) 2006-12-15
CN1809361A (zh) 2006-07-26
IL172156A0 (en) 2006-04-10
DE602004003252T2 (de) 2007-05-03
EA200600270A1 (ru) 2006-06-30
DK1646391T3 (da) 2007-03-19
CA2526852A1 (en) 2005-02-17
EP1646391B1 (de) 2006-11-15
ITMI20031467A1 (it) 2005-01-19
GEP20084307B (en) 2008-02-11
HK1087027A1 (en) 2006-10-06
KR20060033784A (ko) 2006-04-19
US20060211691A1 (en) 2006-09-21
CA2526852C (en) 2011-08-30
AU2004262876A1 (en) 2005-02-17
WO2005014001A1 (en) 2005-02-17
UA81050C2 (en) 2007-11-26
PT1646391E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
ATE410430T1 (de) 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
DE602004020072D1 (de) 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
DE60325770D1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
ATE395871T1 (de) Marknagel zur behandlung von proximalen oberschenkelknochenbrüchen
DE50009504D1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
ATE515261T1 (de) Zusammensetzungen zur behandlung von diabetes
DE60322451D1 (de) 4-Tetrazolyl-4-Phenylpiperidinderivate zur Schmerzbehandlung
DE602004028763D1 (de) Te zur behandlung von virenerkrankungen
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
DE602005007717D1 (de) Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
DE602005021970D1 (de) Verwendung von peptidverbindungen zur behandlung von schmerzen durch knochenkrebs, chemotherapie- und nucleosid-bedingten schmerzen
DE502005010499D1 (de) Implantat zur Behandlung von Fettsucht
DE502004010131D1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
DE602006007323D1 (de) VERWENDUNG VON BAFF ZUR BEHANDLUNG Th2-INDUZIERTER LEIDEN
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
DE602004022035D1 (de) Verwendung von pthalide derivativen zur behandlung
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
DE602004022153D1 (de) Verbindungen zur behandlung von obesitas
DE602004019576D1 (de) Zur behandlung von schmerzen geeignete piperazine
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
DE60214355D1 (de) Exemestan zur behandlung von hormonabhängigen störungen
ATE482707T1 (de) 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen
DE602005015442D1 (de) Kollagen-polyvinylpyrrolidon zur behandlung von osteoarthritis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition